Cash flow generation remains highly volatile, evidenced by an OCF/NI ratio of -2.05 in 2025Q4 and a capital expenditure spike that consumed 93.2% of quarterly revenue.
| Cash from Operations | 141.12K | -7.72M | -651.91K | -187.12K | 4.05M | 2.64M | 7.1M | 273.9K |
| Operating CF Margin % | 0.76% | -32.39% | -2.21% | -0.63% | 15.9% | 14.51% | 43.33% | 2.54% |
| Operating CF Growth % | 101.83% | -1084.78% | -248.39% | -104.62% | 53.35% | -62.8% | 2493.98% | - |
| Net Income | -1.99M | 417.68K | 4.61M | 6.24M | 4.59M | 3.03M | 2.57M | 223.38K |
| Depreciation & Amortization | 1.29M | 1.28M | 1.18M | 369.5K | 286.69K | 230.6K | 226.63K | 224.08K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 1.41K | 19.01K | 29.11K | -7.75K | -5.15K | 61.48K |
| Other Non-Cash Items | 2.3M | 2.25M | -6.7M | 18.02K | -200.9K | 103.42K | 17.88K | 275.67K |
| Working Capital Changes | -1.45M | -11.67M | 249.45K | -6.83M | -652.58K | -709.86K | 4.29M | -510.72K |
| Change in Receivables | -108.81K | -6.81M | 2.08M | -1.3M | -89.54K | -284.55K | -2.91M | -145.38K |
| Change in Inventory | -3.83M | -6.12M | -3.84M | -564.73K | -608.27K | -1.39M | 6.68M | 452.85K |
| Change in Payables | 6.11M | 1.92M | 833.55K | -141.93K | -969.41K | -1.98M | -78.36K | -1.12M |
| Cash from Investing | -10M | -15.73K | -1.19M | -3.06M | -7.44M | -3M | -7.99M | -1.68M |
| Capital Expenditures | -10M | -7.05K | -731.1K | -4.74M | -4.75M | -4.33M | -8.43M | -1.68M |
| CapEx % of Revenue | 53.54% | 0.03% | 2.48% | 15.83% | 18.65% | 23.78% | 51.41% | 15.62% |
| Acquisitions | 0 | 0 | 0 | 1.61K | -1M | 1.33M | 435.96K | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -8.74K | -454.5K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 15.45M | 8.76M | 1.16M | 2.26M | 5.35M | 112.49K | 368.72K | 2.02M |
| Debt Issued (Net) | 4.78M | 3.15M | -875.36K | 2.26M | -5.4M | 394.05K | 368.72K | 2.02M |
| Equity Issued (Net) | 10.67M | 5.6M | 2.03M | 140 | 11.27M | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 5K | 3.06K | 0 | -521.65K | -281.55K | 0 | 0 |
| Net Change in Cash | 5.61M | 545.91K | -729.56K | -1.06M | 1.85M | -240.66K | -527.09K | 820.86K |
| Free Cash Flow | -4.23M | -7.73M | -713.82K | -4.92M | -700.78K | -1.69M | 29.93K | -1.41M |
| FCF Margin % | -22.66% | -32.42% | -2.42% | -16.46% | -2.75% | -9.28% | 0.18% | -13.08% |
| FCF Growth % | 45.27% | -982.89% | 85.5% | -602.49% | 58.53% | -5746.03% | 102.12% | - |
| FCF per Share | -1.54 | -3.22 | -0.78 | -5.86 | -1.04 | -3.24 | 0.06 | -2.73 |
| FCF Conversion (FCF/Net Income) | -0.07x | -19.40x | -0.14x | -0.03x | 0.88x | 0.87x | 2.76x | 1.23x |
| Interest Paid | 0 | 303.32K | 238.22K | 446.88K | 417.27K | 0 | 333.19K | 286.46K |
| Taxes Paid | 0 | 0 | 478.68K | 2.29M | 2.41K | 0 | 115.18K | 336.39K |
Persistent negative operating cash
As reported in recent financial filings, the company's OCF/NI ratio has exhibited extreme volatility, reaching -2.05 in 2025Q4, which highlights a persistent inability to convert accounting profits into actual cash inflows, suggesting that reported earnings may not reflect the underlying economic reality of the business.
The wide divergence between net income and operating cash flow suggests that accrual-based accounting may be masking significant operational inefficiencies. Investors should monitor whether this disconnect stems from aggressive revenue recognition or an inability to collect on receivables in a timely manner.
Based on the provided cash flow statements, the company's FCF margin has remained largely negative over the last ten quarters, with a brief, anomalous positive spike in 2025Q4 that appears driven by working capital shifts rather than sustainable improvements in core operational cash generation.
The consistent failure to generate positive free cash flow indicates that the business model is currently capital-consumptive rather than self-sustaining. This trajectory suggests that the company may require external financing if it cannot stabilize its core margins and reduce its reliance on working capital fluctuations.
According to historical data, the company's capital expenditure reached a significant 93.2% of revenue in 2025Q4, a sharp departure from previous periods, which may indicate a desperate attempt to upgrade aging infrastructure or a one-time investment that could further strain the firm's limited liquidity.
High capital intensity relative to revenue, especially during a period of top-line contraction, warrants further investigation into the necessity of these expenditures. It appears that the company is struggling to balance the need for asset maintenance with the reality of its shrinking revenue base.
As indicated by the quarterly cash flow statements, working capital changes have been the primary driver of cash flow volatility, with a massive $3.9 million inflow in 2025Q4 following several quarters of significant cash outflows, suggesting an inconsistent and potentially unsustainable approach to managing current assets.
The erratic nature of working capital changes implies that the company may be pulling levers to manage short-term liquidity, such as delaying payables or accelerating collections. This behavior often precedes periods of operational stress and suggests that the underlying cash cycle is not yet optimized for stability.
Quick answers to the most common questions about buying BON stock.
Bon Natural Life Limited (BON) generated $0.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Bon Natural Life Limited (BON) reported negative free cash flow of $4.2M in 2025, indicating capital requirements exceeded cash from operations.
Bon Natural Life Limited (BON) spent $10.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.